| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/31/2000 | DE19856475A1 Nichtsteroidale Entzündungshemmer Nonsteroidal anti-inflammatory drugs |
| 05/31/2000 | CN1255162A Protease inhibitors |
| 05/31/2000 | CN1255161A Protease inhibitors |
| 05/31/2000 | CN1255142A B-ring estratriene diol sulphates |
| 05/31/2000 | CN1255119A Protease inhibitors |
| 05/31/2000 | CN1255066A Plant extracts for the treatment of increase bone resorption |
| 05/31/2000 | CN1254586A Wumagao-for treating arthralgia |
| 05/31/2000 | CN1254582A Chinese patent medicine for treating rheumatic hyperosteogeny and its preparing process |
| 05/31/2000 | CN1254579A Exterior-applied liniment for treating hyperosteogeny |
| 05/31/2000 | CN1254575A Exterior-applied powder medicine for treating lumbar intervertebral disk protrusion and preparing process |
| 05/31/2000 | CN1052909C Medicine for treating osteoproliferation disease |
| 05/30/2000 | US6069162 Indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production |
| 05/30/2000 | US6069158 10,11-dihydro-3(3-(4-amino-2-pyridylamino)-1-propyloxy)-5h-dib enzo(a,d)cycloheptene-10-acetic acid |
| 05/25/2000 | WO2000029623A2 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | WO2000029583A2 Immunoglobulin superfamily proteins |
| 05/25/2000 | WO2000029551A2 Cells, culture methods, and their use in autologous transplantation therapy |
| 05/25/2000 | WO2000029446A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 05/25/2000 | WO2000029445A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 05/25/2000 | WO2000029435A1 12 human secreted proteins |
| 05/25/2000 | WO2000029422A1 31 human secreted proteins |
| 05/25/2000 | WO2000029408A1 Morpholino-ethoxybenzofuran protease inhibitors |
| 05/25/2000 | WO2000029401A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/25/2000 | WO2000029381A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 05/25/2000 | WO2000028983A1 Novel 4-dedimethy laminotetra cycline derivatives |
| 05/25/2000 | WO2000028982A2 Increasing bone strength with selected bisphosphonates |
| 05/25/2000 | WO2000028973A1 Process for preparing oral calcium compositions |
| 05/25/2000 | WO2000015247A3 Methods of treating multiple myeloma and myeloma-induced bone resorption using integrin antagonists |
| 05/25/2000 | WO2000012049A3 A method for the treatment of staphylococcal disease |
| 05/25/2000 | WO1999053939A9 Treatment of osteoporosis with leptin |
| 05/25/2000 | DE19853487A1 Use of dialkyl fumarate for treating transplant rejection and autoimmune disease |
| 05/25/2000 | DE19850986A1 Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen The genetic imprint of cells and their use in the prophylaxis and treatment of diseases |
| 05/25/2000 | CA2351576A1 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/25/2000 | CA2351170A1 Humanized antibody specific for human 4-1bb and pharmaceutical composition comprising same |
| 05/25/2000 | CA2350785A1 31 human secreted proteins |
| 05/25/2000 | CA2350443A1 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 05/25/2000 | CA2350391A1 Method for inhibiting macrophage infiltration using monoclonal anti-alpha-d-antibodies |
| 05/25/2000 | CA2348824A1 12 human secreted proteins |
| 05/25/2000 | CA2348459A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/24/2000 | EP1002802A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1002799A1 Optically pure androgen mediator |
| 05/24/2000 | EP1002081A2 Delayed progression to aids by a missense allele of the ccr2 gene |
| 05/24/2000 | EP1002074A1 Calcium-binding phosphoprotein |
| 05/24/2000 | EP1001986A2 Pharmaceuticals for modulating hormone responsiveness |
| 05/24/2000 | EP1001984A1 NOVEL ESTROGEN RECEPTOR $g(b) AND ISOFORMS |
| 05/24/2000 | EP1001983A1 NOVEL ESTROGEN $g(b) RECEPTOR AND ISOFORMS |
| 05/24/2000 | EP1001979A1 Cyclic azapeptides with angiogenic effect |
| 05/24/2000 | EP1001974A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001973A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 05/24/2000 | EP1001970A1 Dipeptide derivatives as growth hormone secretagogues |
| 05/24/2000 | EP1001946A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?1ck TYROSINE KINASES |
| 05/24/2000 | EP1001945A1 QUINOLINE AND QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56?lck TYROSINE KINASES |
| 05/24/2000 | EP1001933A1 Caspases and apoptosis |
| 05/24/2000 | EP1001930A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 05/24/2000 | EP1001805A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof |
| 05/24/2000 | EP1001802A1 A combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor |
| 05/24/2000 | EP1001755A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 05/24/2000 | EP0687270B1 Osteogenic growth oligopeptides and pharmaceutical compositions containing them |
| 05/24/2000 | EP0626969B1 CoA-IT AND PAF INHIBITORS |
| 05/24/2000 | CN1254347A Analogs of parathyroid hormone |
| 05/24/2000 | CN1254344A Estrogenic 10-Noradnrost-17-one derivatives with aromatic B-ring |
| 05/24/2000 | CN1254341A Pharmaceutically accpetable salts of 3-hydroxy-estr-5-(10)-en-17-one 3-sulphate active as estrogens |
| 05/24/2000 | CN1254337A N-hydroxy 4-sulfonyl butyramide compounds |
| 05/24/2000 | CN1254335A Nicotinamide derivatives |
| 05/24/2000 | CN1254333A Immunotherapeutic imides/amides |
| 05/24/2000 | CN1254293A Targeted therapeutic delivery of vitamin D compounds |
| 05/24/2000 | CN1253948A Substituted tricyclic compound |
| 05/24/2000 | CN1253811A Ointment for curing rheumatic arthritis and its preparation method |
| 05/24/2000 | CN1052651C Traditional Chinese medicine for curing prolapse of lumbar intervertebral disc and preparing method thereof |
| 05/24/2000 | CN1052638C 'Xiaofengtong' injection and its preparing method |
| 05/24/2000 | CN1052637C Use of kingcup |
| 05/23/2000 | US6066730 Boronic ester and acid compounds, synthesis and uses |
| 05/23/2000 | US6066657 For the treatment of disease states associated with proteins which mediate cellular activity, for example by inhibiting tumor necrosis factor or phosphodiesterase iv |
| 05/18/2000 | WO2000028554A1 Products and methods for brachytherapy |
| 05/18/2000 | WO2000028323A1 Methods for identifying modulators of bs69 activity |
| 05/18/2000 | WO2000028035A1 CHEMOKINE β-7 |
| 05/18/2000 | WO2000028027A2 Corticosteroid synthesis-associated genes |
| 05/18/2000 | WO2000028022A1 Pge synthase and methods and means for modulating its activity |
| 05/18/2000 | WO2000028019A2 Antisense oligomer |
| 05/18/2000 | WO2000028010A2 The genetic determination of genes and its use for the prophylaxis and therapy of diseases |
| 05/18/2000 | WO2000027887A2 Cross-linked hyaluronic acids and medical uses thereof |
| 05/18/2000 | WO2000027870A1 Novel amino acid sequences, dna encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof |
| 05/18/2000 | WO2000027868A2 Connective tissue growth factor (ctgf) and methods of use |
| 05/18/2000 | WO2000027845A1 Spiro-indolines as y5 receptor antagonists |
| 05/18/2000 | WO2000027842A1 Compounds |
| 05/18/2000 | WO2000027832A2 Thiazole derivatives as ppar gamma ligands |
| 05/18/2000 | WO2000027822A2 Tricyclic pyrazole derivatives |
| 05/18/2000 | WO2000027819A2 Antrhranilic acid amides and the use thereof as medicaments |
| 05/18/2000 | WO2000027808A1 N-arylsulfonyl amino acid omega amides |
| 05/18/2000 | WO2000027802A1 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof |
| 05/18/2000 | WO2000027792A1 Novel compounds and medicinal use thereof |
| 05/18/2000 | WO2000027431A1 Method of treating arthritis with human parvovirus b19 antigens or antibodies against same |
| 05/18/2000 | WO2000027422A2 Methods and compositions for treating or preventing peripheral neuropathies |
| 05/18/2000 | WO2000027414A2 Inhibition of the formation of vascular hyperpermeability |
| 05/18/2000 | WO2000027378A2 Cystine derivatives as therapeutic agents for matrix metalloprotease related diseases |
| 05/18/2000 | WO2000027377A2 Phosphinate peptide analogs for the treatment of fibrotic disorders |
| 05/18/2000 | WO2000027359A1 An inhalation system |
| 05/18/2000 | WO2000009130A3 New pharmaceutical uses for nos inhibitors |
| 05/18/2000 | WO2000008202A3 3-methylidenyl-2-indolinone modulators of protein kinase |
| 05/18/2000 | WO2000007544A3 Vitronectin receptor antagonists |
| 05/18/2000 | WO2000006140A3 Use of moclobemide for treating certain phsychiatric and medical disorders |